Skip to Content

Ultragenyx

RARE

Buy $RARE at eToro
Rank 2372
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 60 LEVERONI COURT, NOVATO, CA, US

Ultragenyx - Key figures

Market cap 4.21 Billion
Revenue 331.95 Million
Profit -161,755,000
P/E Ratio No information
P/s Ratio 12.69
Buy $RARE at eToro

Ultragenyx - Description

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States.

The company is headquartered in Novato, California.